R. Goldman-Leikin

Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.

A. M. Zimmer, L. Gordon, S. Rosen, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cell sedimentation with gravity activation

G. Czerlinski, R. Goldman-Leikin, D. Reid, 1988, Cell Biophysics.

T-cell receptor alpha-chain gene is split in a human T-cell leukemia cell line with a t(11;14)(p15;q11).

J. Rowley, M. L. Le Beau, M. Diaz, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies.

A. M. Zimmer, S. Rosen, S. Spies, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Stability of radioiodinated monoclonal antibodies: in vitro storage and plasma analysis.

A. M. Zimmer, S. Rosen, W. Spies, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Characterization of a novel myeloma cell line, MM.1.

M. L. Le Beau, H. Salwen, R. Goldman-Leikin, 1989, The Journal of laboratory and clinical medicine.

Characterization of monoclonal antibodies to the sperm-specific lactate dehydrogenase isozyme.

E. Goldberg, R. Goldman-Leikin, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.

A. M. Zimmer, S. Rosen, L. Manzel, 1988, Experimental hematology.

Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis.

E. A. Silverstein, R. Goldman-Leikin, J. Kazikiewicz, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.